Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI.

Mulay SR, Honarpisheh MM, Foresto-Neto O, Shi C, Desai J, Zhao ZB, Marschner JA, Popper B, Buhl EM, Boor P, Linkermann A, Liapis H, Bilyy R, Herrmann M, Romagnani P, Belevich I, Jokitalo E, Becker JU, Anders HJ.

J Am Soc Nephrol. 2019 Jul 11. pii: ASN.2018121218. doi: 10.1681/ASN.2018121218. [Epub ahead of print]

PMID:
31296606
2.

HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway.

Aljabri A, Vijayan V, Stankov M, Nikolin C, Figueiredo C, Blasczyk R, Becker JU, Linkermann A, Immenschuh S.

Cell Death Dis. 2019 Mar 8;10(3):235. doi: 10.1038/s41419-019-1319-5.

3.

The pathological features of regulated necrosis.

Tonnus W, Meyer C, Paliege A, Belavgeni A, von Mässenhausen A, Bornstein SR, Hugo C, Becker JU, Linkermann A.

J Pathol. 2019 Apr;247(5):697-707. doi: 10.1002/path.5248. Epub 2019 Feb 25. Review.

PMID:
30714148
4.

The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury.

Späth MR, Bartram MP, Palacio-Escat N, Hoyer KJR, Debes C, Demir F, Schroeter CB, Mandel AM, Grundmann F, Ciarimboli G, Beyer A, Kizhakkedathu JN, Brodesser S, Göbel H, Becker JU, Benzing T, Schermer B, Höhne M, Burst V, Saez-Rodriguez J, Huesgen PF, Müller RU, Rinschen MM.

Kidney Int. 2019 Feb;95(2):333-349. doi: 10.1016/j.kint.2018.08.037. Epub 2018 Dec 3.

PMID:
30522767
5.

A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology.

Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasińska A, Rabant M, Racusen LC, Solez K, Becker JU.

Transplantation. 2018 Nov;102(11):1795-1814. doi: 10.1097/TP.0000000000002366. Review. Erratum in: Transplantation. 2018 Dec;102(12):e497.

PMID:
30028786
6.

Pathological manifestations of Farber disease in a new mouse model.

Beckmann N, Kadow S, Schumacher F, Göthert JR, Kesper S, Draeger A, Schulz-Schaeffer WJ, Wang J, Becker JU, Kramer M, Kühn C, Kleuser B, Becker KA, Gulbins E, Carpinteiro A.

Biol Chem. 2018 Sep 25;399(10):1183-1202. doi: 10.1515/hsz-2018-0170.

7.

Correction to: Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 May 24;9(6):622. doi: 10.1038/s41419-018-0638-2.

8.

[Antifreeze poisoning : The case of a patient with repeated ethylene glycol poisoning].

Prinz J, Böll B, von Bergwelt M, Burst V, Becker JU, Carvalho-Fiel D, Shimabukuro-Vornhagen A, Kochanek M.

Med Klin Intensivmed Notfmed. 2019 Mar;114(2):159-163. doi: 10.1007/s00063-018-0439-5. Epub 2018 Apr 12. German.

PMID:
29651677
9.

Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2018 Apr 12;8(1):6003. doi: 10.1038/s41598-018-23760-1.

10.

Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 Mar 2;9(3):359. doi: 10.1038/s41419-018-0394-3. Erratum in: Cell Death Dis. 2018 May 24;9(6):622.

11.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

12.

Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring.

Hackl A, Becker JU, Körner LM, Ehren R, Habbig S, Nüsken E, Nüsken KD, Ebner K, Liebau MC, Müller C, Pohl M, Weber LT.

Pediatr Nephrol. 2018 Apr;33(4):619-629. doi: 10.1007/s00467-017-3846-6. Epub 2017 Nov 25.

PMID:
29177628
13.

Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2017 Nov 6;7(1):14554. doi: 10.1038/s41598-017-14674-5. Erratum in: Sci Rep. 2018 Apr 12;8(1):6003.

14.

[Report from the Heart, Vascular, Renal, and Transplantation Pathology Working Group].

Becker JU.

Pathologe. 2017 Nov;38(Suppl 2):228. doi: 10.1007/s00292-017-0376-8. German. No abstract available.

PMID:
29098366
15.

Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.

Schreiber A, Rousselle A, Becker JU, von Mässenhausen A, Linkermann A, Kettritz R.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9618-E9625. doi: 10.1073/pnas.1708247114. Epub 2017 Oct 24.

16.

Regulation of Arthritis Severity by the Acid Sphingomyelinase.

Beckmann N, Becker KA, Walter S, Becker JU, Kramer M, Hessler G, Weber S, Göthert JR, Fassbender K, Gulbins E, Carpinteiro A.

Cell Physiol Biochem. 2017;43(4):1460-1471. doi: 10.1159/000481968. Epub 2017 Oct 16.

17.

ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.

Gong YN, Guy C, Olauson H, Becker JU, Yang M, Fitzgerald P, Linkermann A, Green DR.

Cell. 2017 Apr 6;169(2):286-300.e16. doi: 10.1016/j.cell.2017.03.020.

18.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

19.

Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries.

Bábíčková J, Klinkhammer BM, Buhl EM, Djudjaj S, Hoss M, Heymann F, Tacke F, Floege J, Becker JU, Boor P.

Kidney Int. 2017 Jan;91(1):70-85. doi: 10.1016/j.kint.2016.07.038. Epub 2016 Sep 24.

PMID:
27678159
20.

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, Cattran D, Cook HT, Coppo R, Feehally J, Pani A, Perkowska-Ptasinska A, Roberts IS, Soares MF, Trimarchi H, Wang S, Yuzawa Y, Zhang H, Troyanov S, Katafuchi R.

J Am Soc Nephrol. 2017 Feb;28(2):691-701. doi: 10.1681/ASN.2016040433. Epub 2016 Sep 9. Erratum in: J Am Soc Nephrol. 2017 May;28(5):1665.

21.

Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy.

Bockmeyer CL, Säuberlich K, Wittig J, Eßer M, Roeder SS, Vester U, Hoyer PF, Agustian PA, Zeuschner P, Amann K, Daniel C, Becker JU.

Sci Rep. 2016 Aug 24;6:31992. doi: 10.1038/srep31992.

22.

Live or Let Die: Is There any Cell Death in Podocytes?

Braun F, Becker JU, Brinkkoetter PT.

Semin Nephrol. 2016 May;36(3):208-19. doi: 10.1016/j.semnephrol.2016.03.008. Review.

PMID:
27339386
23.

Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).

Abbas M, Steffens S, Bellut M, Eggers H, Großhennig A, Becker JU, Wegener G, Schrader AJ, Grünwald V, Ivanyi P.

Med Oncol. 2016 Jul;33(7):80. doi: 10.1007/s12032-016-0794-0. Epub 2016 Jun 17.

PMID:
27317388
24.

Current status of pediatric renal transplant pathology.

Becker JU.

Pediatr Nephrol. 2017 Mar;32(3):425-437. doi: 10.1007/s00467-016-3381-x. Epub 2016 May 24. Review.

PMID:
27221522
25.

Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?

Abbas M, Steffens S, Bellut M, Becker JU, Großhennig A, Eggers H, Wegener G, Kuczyk MA, Kreipe HH, Grünwald V, Schrader AJ, Ivanyi P.

Med Oncol. 2016 Jun;33(6):59. doi: 10.1007/s12032-016-0770-8. Epub 2016 May 10.

PMID:
27165272
26.

German recommendations for pretransplantation donor kidney biopsies.

Pisarski P, Schleicher C, Hauser I, Becker JU.

Langenbecks Arch Surg. 2016 Mar;401(2):133-40. doi: 10.1007/s00423-016-1384-5. Epub 2016 Mar 19. Review.

PMID:
26994917
27.

Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?

Becker JU, Chang A, Nickeleit V, Randhawa P, Roufosse C.

Am J Transplant. 2016 Sep;16(9):2654-60. doi: 10.1111/ajt.13784. Epub 2016 May 5.

28.

Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a Subset of Human Transplant Glomerulopathy.

Grau V, Zeuschner P, Immenschuh S, Bockmeyer CL, Zell S, Wittig J, Säuberlich K, Abbas M, Padberg W, Meyer-Schwesinger C, von Brandenstein M, Schlosser M, Dieplinger G, Galliford J, Clarke C, Roufosse C, Becker JU.

Transplantation. 2016 May;100(5):1004-14. doi: 10.1097/TP.0000000000001068.

PMID:
26895216
29.

TRPC6 G757D Loss-of-Function Mutation Associates with FSGS.

Riehle M, Büscher AK, Gohlke BO, Kaßmann M, Kolatsi-Joannou M, Bräsen JH, Nagel M, Becker JU, Winyard P, Hoyer PF, Preissner R, Krautwurst D, Gollasch M, Weber S, Harteneck C.

J Am Soc Nephrol. 2016 Sep;27(9):2771-83. doi: 10.1681/ASN.2015030318. Epub 2016 Feb 18.

30.

Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.

Zilian E, Saragih H, Vijayan V, Hiller O, Figueiredo C, Aljabri A, Blasczyk R, Theilmeier G, Becker JU, Larmann J, Immenschuh S.

PLoS One. 2015 Dec 21;10(12):e0145306. doi: 10.1371/journal.pone.0145306. eCollection 2015.

31.

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.

Leifheit-Nestler M, Große Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D.

Nephrol Dial Transplant. 2016 Jul;31(7):1088-99. doi: 10.1093/ndt/gfv421. Epub 2015 Dec 17.

32.

[Report from the cardiac, vascular, renal, and transplantation pathology working group].

Becker JU.

Pathologe. 2015 Nov;36 Suppl 2:223-4. doi: 10.1007/s00292-015-0101-4. German. No abstract available.

PMID:
26507555
33.

Effect of TNF-alpha blockade on coagulopathy and endothelial cell activation in xenoperfused porcine kidneys.

Ramackers W, Klose J, Tiede A, Werwitzke S, Rataj D, Friedrich L, Johanning K, Vondran FW, Bergmann S, Schuettler W, Bockmeyer CL, Becker JU, Klempnauer J, Winkler M.

Xenotransplantation. 2015 Jul-Aug;22(4):284-94. doi: 10.1111/xen.12179. Erratum in: Xenotransplantation. 2015 Nov-Dec;22(6):493.

PMID:
26216261
34.

Role of immunohistochemistry and fluorescence in-situ hybridization (FISH) in the diagnosis of spindle and round cell tumors of the kidney.

Abbas M, Dämmrich ME, Braubach P, Kramer MW, Grünwald V, Merseburger AS, Herrmann TR, Becker JU, Kreipe HH.

J Egypt Natl Canc Inst. 2015 Sep;27(3):173-8. doi: 10.1016/j.jnci.2015.04.005. Epub 2015 May 11.

35.

Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated Vasculitis.

Bertram A, Lovric S, Engel A, Beese M, Wyss K, Hertel B, Park JK, Becker JU, Kegel J, Haller H, Haubitz M, Kirsch T.

J Am Soc Nephrol. 2015 Nov;26(11):2860-70. doi: 10.1681/ASN.2014050477. Epub 2015 Mar 18.

36.

A rolling circle amplification screen for polyomaviruses other than BKPyV in renal transplant recipients confirms high prevalence of urinary JCPyV shedding.

Kluba J, Linnenweber-Held S, Heim A, Ang AM, Raggub L, Broecker V, Becker JU, Schulz TF, Schwarz A, Ganzenmueller T.

Intervirology. 2015;58(2):88-94. doi: 10.1159/000369210. Epub 2015 Feb 13.

37.

Detection of cytomegalovirus (CMV) by real-time PCR in fecal samples for the non-invasive diagnosis of CMV intestinal disease.

Ganzenmueller T, Kluba J, Becker JU, Bachmann O, Heim A.

J Clin Virol. 2014 Dec;61(4):517-22. doi: 10.1016/j.jcv.2014.10.009. Epub 2014 Oct 22.

PMID:
25453330
38.

[Report from the working group on cardiac, vascular, renal and transplantation pathology 2014].

Becker JU, Baba HA.

Pathologe. 2014 Nov;35 Suppl 2:289-90. doi: 10.1007/s00292-014-2014-z. German. No abstract available.

PMID:
25394981
39.

Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation.

Immenschuh S, Zilian E, Dämmrich ME, Schwarz A, Gwinner W, Becker JU, Blume CA.

Transplantation. 2015 Jan;99(1):56-62. doi: 10.1097/TP.0000000000000244. Erratum in: Transplantation. 2016 Mar;100(3):e15.

PMID:
25121474
40.

eEOC-mediated modulation of endothelial autophagy, senescence, and EnMT in murine diabetic nephropathy.

Patschan D, Schwarze K, Henze E, Becker JU, Patschan S, Müller GA.

Am J Physiol Renal Physiol. 2014 Sep 15;307(6):F686-94. doi: 10.1152/ajprenal.00650.2013. Epub 2014 Jul 30.

41.

Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.

Pape L, Becker JU, Immenschuh S, Ahlenstiel T.

Pediatr Nephrol. 2015 Mar;30(3):417-24. doi: 10.1007/s00467-014-2851-2. Epub 2014 May 28. Review.

PMID:
24865478
42.

Primary mucinous adenocarcinoma of the renal pelvis with carcinoma in situ in the ureter.

Abbas M, Kramer MW, Spieker T, Herrman TR, Merseburger AS, Müller KM, Kuczyk MA, Becker JU, Kreipe HH.

J Egypt Natl Canc Inst. 2014 Mar;26(1):51-4. doi: 10.1016/j.jnci.2013.11.002. Epub 2014 Jan 9.

43.

PECAM-1-dependent heme oxygenase-1 regulation via an Nrf2-mediated pathway in endothelial cells.

Saragih H, Zilian E, Jaimes Y, Paine A, Figueiredo C, Eiz-Vesper B, Blasczyk R, Larmann J, Theilmeier G, Burg-Roderfeld M, Andrei-Selmer LC, Becker JU, Santoso S, Immenschuh S.

Thromb Haemost. 2014 Jun;111(6):1077-88. doi: 10.1160/TH13-11-0923. Epub 2014 Feb 6.

PMID:
24500083
44.

Renal phospholipidosis possibly induced by ranolazine.

Scheurle C, Dämmrich M, Becker JU, Baumgärtel MW.

Clin Kidney J. 2014 Feb;7(1):62-4. doi: 10.1093/ckj/sft141. Epub 2013 Dec 10.

45.

Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates.

Bröcker V, Hirzallah M, Gwinner W, Bockmeyer CL, Wittig J, Zell S, Agustian PA, Schwarz A, Ganzenmüller T, Zilian E, Immenschuh S, Becker JU.

Virchows Arch. 2014 Feb;464(2):203-11. doi: 10.1007/s00428-013-1487-0. Epub 2013 Dec 28.

PMID:
24374461
46.

Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.

Bröcker V, Pfaffenbach A, Habicht A, Chatzikyrkou C, Kreipe HH, Haller H, Scheffner I, Gwinner W, Zilian E, Immenschuh S, Schwarz A, Horn PA, Heinemann FM, Becker JU.

Nephrol Dial Transplant. 2013 Dec;28(12):3101-9. doi: 10.1093/ndt/gft373. Epub 2013 Sep 29.

PMID:
24081856
47.

Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis.

Zell S, Schmitt R, Witting S, Kreipe HH, Hussein K, Becker JU.

Nephron Extra. 2013 Jun 6;3(1):50-8. doi: 10.1159/000351046. Print 2013 Jan.

48.

Adenocarcinoma of the urinary bladder, mesonephroid type: a rare case.

Abbas M, Kramer MW, Wolters M, Herrman TR, Becker JU, Kreipe HH.

Rare Tumors. 2013 Mar 1;5(1):e3. doi: 10.4081/rt.2013.e3. Print 2013 Feb 11.

49.

The effect of mTOR-inhibition on NF-κB activity in kidney ischemia-reperfusion injury in mice.

Kezic A, Becker JU, Thaiss F.

Transplant Proc. 2013 Jun;45(5):1708-14. doi: 10.1016/j.transproceed.2013.02.110.

PMID:
23769029
50.

Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease.

Patschan D, Schwarze K, Lange A, Meise N, Henze E, Becker JU, Patschan S, Müller GA.

Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F314-22. doi: 10.1152/ajprenal.00677.2012. Epub 2013 May 15. Erratum in: Am J Physiol Renal Physiol. 2013 Dec 15;305(12):F1813.

Supplemental Content

Loading ...
Support Center